Showing 271-280 of 2216 results for "".
New in My Practice | Devices: Emsculpt from BTL Aesthetics
https://modernaesthetics.com/ma-issues-index/2018-sept-oct/new-in-my-practice-emsculpt-from-btl-aesthetics/34064/What Does Being Ethical Mean in Today's Consumer Market?
https://modernaesthetics.com/ma-issues-index/2013-july-aug/what-does-being-ethical-mean-in-todays-consumer-market/34738/Honoring the Past and Shaping the Future of Energy-Based Devices
https://modernaesthetics.com/programs/modern-aesthetics/honoring-the-past-and-shaping-the-future-of-energy-based-devices/56626/The Future of Beauty is Stacked, Preventive, and Driven by Technology
https://modernaesthetics.com/ma-issues-index/jan-feb-2026-issue/the-future-of-beauty-is-stacked-preventive-and-driven-by-technology/54430/Legalities of Injecting PDGF: Off-Label or Out-of-Bounds?
https://modernaesthetics.com/topics/regenerative-medicine/legalities-of-injecting-pdgf-off-label-or-out-of-bounds/37871/Addressing Visible Signs of Aging and Skin Barrier Damage
https://modernaesthetics.com/ma-supplements/2025-jan-feb-supplement2/addressing-visible-signs-of-aging-and-skin-barrier-damage-1/35429/In Focus: Beauty Trends
https://modernaesthetics.com/topics/skincare/in-focus-beauty-trends/35245/Revision Skincare’s Dermal-Epidermal Junction (D-E-J) Daily Boosting Serum
https://modernaesthetics.com/topics/skincare/revision-skincares-dermal-epidermal-junction-d-e-j-daily-boosting-serum/35219/Buying Devices: Look Before You Leap
https://modernaesthetics.com/topics/practice-development/buying-devices-look-before-you-leap-part-2-dollars-and-good-sense/35217/Part 2: Dollars and Good SenseMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data from